Precigen (PGEN) Liabilities and Shareholders Equity (2012 - 2026)

Precigen (PGEN) has 15 years of Liabilities and Shareholders Equity data on file, last reported at $138.6 million in Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity rose 7.64% year-over-year to $138.6 million in Q1 2026; TTM through Mar 2026 was $567.3 million, a 31.72% increase from a year earlier, with the FY2025 full-year figure at $155.5 million, up 7.05% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $138.6 million, down from $155.5 million in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for PGEN reached as high as $335.6 million in Q1 2022 and fell as low as $73.2 million in Q2 2024.
• Historically, Liabilities and Shareholders Equity has averaged $179.7 million across 5 years, with a median of $155.5 million in 2025.
• Across the five-year window, Liabilities and Shareholders Equity tumbled 64.75% in 2024 and jumped 105.17% in 2025, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $216.0 million in 2022, then slumped by 30.07% to $151.0 million in 2023, then fell by 3.82% to $145.3 million in 2024, then grew by 7.05% to $155.5 million in 2025, then slipped by 10.85% to $138.6 million in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $138.6 million in Q1 2026, $155.5 million in Q4 2025, and $171.3 million in Q3 2025.